127 related articles for article (PubMed ID: 33440291)
1. D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy.
Du C; Zhou M; Jia F; Ruan L; Lu H; Zhang J; Zhu B; Liu X; Chen J; Chai Z; Hu Y
Biomaterials; 2021 Feb; 269():120642. PubMed ID: 33440291
[TBL] [Abstract][Full Text] [Related]
2. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine-cloaked Fe-based metal organic frameworks enable synergistic multidimensional treatment of osteosarcoma.
Wang Y; Williams GR; Zheng Y; Guo H; Chen S; Ren R; Wang T; Xia J; Zhu LM
J Colloid Interface Sci; 2023 Dec; 651():76-92. PubMed ID: 37540932
[TBL] [Abstract][Full Text] [Related]
4. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
Xu W; Lou Y; Chen W; Kang Y
Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
[TBL] [Abstract][Full Text] [Related]
7. Tantalum-Zirconium Co-Doped Metal-Organic Frameworks Sequentially Sensitize Radio-Radiodynamic-Immunotherapy for Metastatic Osteosarcoma.
Li T; Gao M; Wu Z; Yang J; Mo B; Yu S; Gong X; Liu J; Wang W; Luo S; Li R
Adv Sci (Weinh); 2023 Apr; 10(10):e2206779. PubMed ID: 36739599
[TBL] [Abstract][Full Text] [Related]
8. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.
He G; Pan X; Liu X; Zhu Y; Ma Y; Du C; Liu X; Mao C
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48296-48309. PubMed ID: 33054172
[TBL] [Abstract][Full Text] [Related]
10. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
11. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation.
Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R
ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
[TBL] [Abstract][Full Text] [Related]
13. Quercetin-Modified Metal-Organic Frameworks for Dual Sensitization of Radiotherapy in Tumor Tissues by Inhibiting the Carbonic Anhydrase IX.
Ma T; Liu Y; Wu Q; Luo L; Cui Y; Wang X; Chen X; Tan L; Meng X
ACS Nano; 2019 Apr; 13(4):4209-4219. PubMed ID: 30933559
[TBL] [Abstract][Full Text] [Related]
14. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
Sun Y; Wang H; Liu M; Lin F; Hua J
Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.
Sun W; Wang B; Qu XL; Zheng BQ; Huang WD; Sun ZW; Wang CM; Chen Y
Cells; 2019 Dec; 9(1):. PubMed ID: 31905813
[TBL] [Abstract][Full Text] [Related]
18. Heparanase participates in the growth and invasion of human U-2OS osteosarcoma cells and its close relationship with hypoxia-inducible factor-1α in osteosarcoma.
Z CZ; Luo C; Yang Z; Wang L
Neoplasma; 2010; 57(6):562-71. PubMed ID: 20845995
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
Zhang K; Meng X; Yang Z; Dong H; Zhang X
Biomaterials; 2020 Nov; 258():120278. PubMed ID: 32781328
[TBL] [Abstract][Full Text] [Related]
20. 131I-radioisotope modified in PEGylation metal organic frameworks for sensitization in refractory differentiated thyroid cancer treatment.
Jiang S; Yu M; Wang H; Han S; Cheng M; Zhang S; Liu J; Wang X; Dong M
J Biomater Appl; 2021 Nov; 36(5):851-858. PubMed ID: 34254840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
